Table of Contents Author Guidelines Submit a Manuscript
Journal of Cancer Epidemiology
Volume 2015, Article ID 710106, 7 pages
http://dx.doi.org/10.1155/2015/710106
Research Article

Increase in Distant Stage Breast Cancer Incidence Rates in US Women Aged 25–49 Years, 2000–2011: The Stage Migration Hypothesis

Private Practice, 241 Stonecrest Drive, Bristol, CT 06010, USA

Received 19 September 2014; Revised 20 November 2014; Accepted 5 December 2014

Academic Editor: Lance A. Liotta

Copyright © 2015 Anthony P. Polednak. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Johnson, F. L. Chien, and A. Bleyer, “Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009,” JAMA—Journal of the American Medical Association, vol. 309, no. 8, pp. 800–805, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Grady, “Study sees more breast cancer at young age,” New York Times, 2013, http://www.nytimes.com/2013/02/27/health/advanced-breast-cancer-may-be-rising-among-young-women-study-finds.html?_r=0. View at Google Scholar
  3. G. Hortobágyi and P. Conte, “Interpreting cancer biology: refining our therapeutic algorithm in breast cancer,” The Oncologist, vol. 18, no. 4, pp. e8–e10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. R. H. Johnson, F. L. Chien, and A. Bleyer, “Incidence rate of breast cancer in young women—reply,” The Journal of the American Medical Association, vol. 309, no. 23, pp. 2435–2436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Howlader, A. K. Noone, M. Krapcho et al., Eds., SEER Cancer Statistics Review, 1975–2011, National Cancer Institute, Bethesda, Md, USA, 2014.
  6. A. R. Feinstein, D. M. Sosin, and C. K. Wells, “The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer,” The New England Journal of Medicine, vol. 312, no. 25, pp. 1604–1608, 1985. View at Publisher · View at Google Scholar · View at Scopus
  7. National Cancer Institute. Surveillance Research Program, “SEER*Stat software version 8.1.5. SEER Program Database: Incidence-SEER 18 Regs Research Data. Nov 2013 submission (2000–2011),” 2014.
  8. B. K. Edwards, A.-M. Noone, A. B. Mariotto et al., “Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer,” Cancer, vol. 120, no. 9, pp. 1290–1314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Young Jr., S. D. Roffers, L. A. G. Ries et al., Eds., SEER Summary Staging Manual-2000: Codes and Coding Instructions, National Cancer Institute, Bethesda, Md, USA, 2001.
  10. S. B. Edge, D. R. Bryd, C. C. Compton et al., AJCC Cancer Staging Manual, Springer, New York, NY, USA, 7th edition, 2010.
  11. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Breast schema for 1988 Based on AJCC, National Cancer Institute, Washington, DC, USA, 6th edition, 1988, http://seer.cancer.gov/seer.state/variables.seer/ajcc-stage/6th/breast.htm.
  12. N. Breen, J. F. Gentleman, and J. S. Schiller, “Update on mammography trends,” Cancer, vol. 117, no. 10, pp. 2209–2218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. T. Warner, G. A. Colditz, J. R. Palmer, A. H. Partridge, B. A. Rosner, and R. M. Tamimi, “Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40?” Breast Cancer Research and Treatment, vol. 142, no. 1, pp. 165–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. G. Chee, D. V. Nguyen, M. Brown, D. R. Gandara, T. Wun, and P. N. Lara, “Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited,” Archives of Internal Medicine, vol. 168, no. 14, pp. 1541–1549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Mahner, S. Schirrmacher, W. Brenner et al., “Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer,” Annals of Oncology, vol. 19, no. 7, pp. 1249–1254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Niikura, C. M. Costelloe, J. E. Madewell et al., “FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer,” Oncologist, vol. 16, no. 8, pp. 1111–1119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Groves, M. Shastry, S. Ben-Haim et al., “Defining the role of PET-CT in staging early breast cancer,” Oncologist, vol. 17, no. 5, pp. 613–619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Costelloe, E. M. Rohren, J. E. Madewell et al., “Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis,” The Lancet Oncology, vol. 10, no. 6, pp. 606–614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Groheux, S. Giacchetti, M. Espié et al., “The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study,” Journal of Nuclear Medicine, vol. 52, no. 10, pp. 1526–1534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Wahl, “Current status of PET in breast cancer imaging, staging, and therapy,” Seminars in Roentgenology, vol. 36, no. 3, pp. 250–260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Wu and S. S. Gambhir, “Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives,” Clinical Breast Cancer, vol. 4, no. 1, pp. S55–S63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. R. W. Carlson and B. McCormick, “Update: NCCN breast cancer clinical practice guidelines,” Journal of the National Comprehensive Cancer Network, vol. 3, supplement 1, pp. S7–S11, 2005. View at Google Scholar · View at Scopus
  23. D. Groheux, E. Hindié, M. Delord et al., “Prognostic impact of 18FDG-PET-CT findings in clinical stage III and IIB breast cancer,” Journal of the National Cancer Institute, vol. 104, no. 24, pp. 1879–1887, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. L. E. Schnipper, T. J. Smith, D. Raghavan et al., “American society of clinical oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology,” Journal of Clinical Oncology, vol. 30, no. 14, pp. 1715–1724, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. L. Crivello, K. Ruth, E. R. Sigurdson et al., “Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population,” Annals of Surgical Oncology, vol. 20, no. 1, pp. 102–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. N. MdPaiman, S. A. Md Ali, R. MdZin et al., “Estrogen receptor-negative breast ductal carcinoma: clinicopathological features and Mib-1 (Ki-67) proliferative index association,” PLoS ONE, vol. 9, no. 2, Article ID e89172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Pagani, K. N. Price, R. D. Gelber et al., “Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century,” Breast Cancer Research and Treatment, vol. 117, no. 2, pp. 319–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. F. Anderson, H. A. Katki, and P. S. Rosenberg, “Incidence of breast cancer in the United States: current and future trends,” Journal of the National Cancer Institute, vol. 103, no. 18, pp. 1397–1402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. X. R. Yang, J. Chang-Clause, E. L. Goode et al., “Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies,” Journal of the National Cancer Institute, vol. 103, no. 3, pp. 250–263, 2011. View at Publisher · View at Google Scholar
  30. N. Hou and D. Huo, “Incidence rate of breast cancer in young women,” JAMA—Journal of the American Medical Association, vol. 309, no. 23, p. 2433, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. T. J. Mathews and B. E. Hamilton, “Delayed childbearing: more women are having their first child later in life,” NCHS Data Brief 21, 2009. View at Google Scholar
  32. Y. Y. Lee, C. L. Roberts, T. Dobbins et al., “Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study,” BJOG, vol. 119, no. 13, pp. 1572–1582, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. K. Pal, M. Dehaven, R. A. Nelson et al., “Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer,” BMC Cancer, vol. 12, article 435, 2012. View at Publisher · View at Google Scholar · View at Scopus